Pioglitazone, etoricoxib, interferon-[alpha], and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial

We enrolled 45 patients with metastatic renal cell carcinoma (RCC) at a progressive disease between March 2003 and April 2008 to assess the impact of an anti-inflammatory treatment regime in combination with metronomic low-dose chemotherapy. 42% of the patients had been systemically pre-treated. The...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Medical oncology (Northwood, London, England) London, England), 2012-06, Vol.29 (2), p.799
Hauptverfasser:	Walter, B, Schrettenbrunner, I, Vogelhuber, M, Grassinger, J, Bross, K, Wilke, J, Suedhoff, T, Berand, A, Wieland, W F, Rogenhofer, S, Andreesen, R, Reichle, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!